It is also well established that mutation carriers are significantly enriched in those women with ovarian cancer who also have a strong family history of breast and/or ovarian cancer, although a cancer family history is not a reliable method for identifying women with BRCA1/BRCA2 mutations [14,22,23]. This evidence concerns the gene BRCA2 and ovarian cancer.